Targeting Diagnosis of High-Risk Papillary Thyroid Carcinoma Using Ultrasound Contrast Agent With the BRAF V600E Mutation: An Experimental Study.

Published in: Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine (2022)

antibody could be regarded as a potential targeted ultrasound contrast agent for the diagnosis of high-risk PTC.

Keyphrases